These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 19138682)
1. Sialic acid moiety of apolipoprotein E and its impact on the formation of lipoprotein particles in human cerebrospinal fluid. Kawasaki K; Ogiwara N; Sugano M; Okumura N; Yamauchi K Clin Chim Acta; 2009 Apr; 402(1-2):61-6. PubMed ID: 19138682 [TBL] [Abstract][Full Text] [Related]
2. [Characterization of sialo-apolipoprotein E in human cerebrospinal fluid]. Yamauchi K Rinsho Byori; 2009 May; 57(5):436-44. PubMed ID: 19522249 [TBL] [Abstract][Full Text] [Related]
3. Effect of apolipoprotein E (apoE) phenotype on the apoE content of CSF-HDL in children. Hirayama S; Miida T; Obayashi K; Yamazaki F; Yamazaki-Sakurai M; Ito M; Saito Y; Hanyu O; Suzuki K; Aizawa Y Clin Chim Acta; 2005 Jun; 356(1-2):110-6. PubMed ID: 15936307 [TBL] [Abstract][Full Text] [Related]
4. Predominant apolipoprotein J exists as lipid-poor mixtures in cerebrospinal fluid. Suzuki T; Tozuka M; Kazuyoshi Y; Sugano M; Nakabayashi T; Okumura N; Hidaka H; Katsuyama T; Higuchi K Ann Clin Lab Sci; 2002; 32(4):369-76. PubMed ID: 12458888 [TBL] [Abstract][Full Text] [Related]
5. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro. Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933 [TBL] [Abstract][Full Text] [Related]
6. Liquid chromatography-tandem mass spectrometry assay for the quantification of free and total sialic acid in human cerebrospinal fluid. van der Ham M; de Koning TJ; Lefeber D; Fleer A; Prinsen BH; de Sain-van der Velden MG J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1098-102. PubMed ID: 20362517 [TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid lipoproteins in Alzheimer's disease. Bassett CN; Montine KS; Neely MD; Swift LL; Montine TJ Microsc Res Tech; 2000 Aug; 50(4):282-6. PubMed ID: 10936881 [TBL] [Abstract][Full Text] [Related]
8. Sialic acid moiety of apolipoprotein E3 at Thr(194) affects its interaction with beta-amyloid(1-42) peptides. Sugano M; Yamauchi K; Kawasaki K; Tozuka M; Fujita K; Okumura N; Ota H Clin Chim Acta; 2008 Feb; 388(1-2):123-9. PubMed ID: 18023277 [TBL] [Abstract][Full Text] [Related]
9. Characterization of apolipoprotein E-containing lipoproteins in cerebrospinal fluid: effect of phenotype on the distribution of apolipoprotein E. Yamauchi K; Tozuka M; Hidaka H; Hidaka E; Kondo Y; Katsuyama T Clin Chem; 1999 Sep; 45(9):1431-8. PubMed ID: 10471645 [TBL] [Abstract][Full Text] [Related]
10. An improved fluorometric high-performance liquid chromatography method for sialic acid determination: an internal standard method and its application to sialic acid analysis of human apolipoprotein E. Ito M; Ikeda K; Suzuki Y; Tanaka K; Saito M Anal Biochem; 2002 Jan; 300(2):260-6. PubMed ID: 11779119 [TBL] [Abstract][Full Text] [Related]
11. Remodeling of cerebrospinal fluid lipoprotein particles after human traumatic brain injury. Kay AD; Day SP; Kerr M; Nicoll JA; Packard CJ; Caslake MJ J Neurotrauma; 2003 Aug; 20(8):717-23. PubMed ID: 12965051 [TBL] [Abstract][Full Text] [Related]
12. Novel large apolipoprotein E-containing lipoproteins of density 1.006-1.060 g/ml in human cerebrospinal fluid. Guyton JR; Miller SE; Martin ME; Khan WA; Roses AD; Strittmatter WJ J Neurochem; 1998 Mar; 70(3):1235-40. PubMed ID: 9489746 [TBL] [Abstract][Full Text] [Related]
14. Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins. Koudinov AR; Koudinova NV; Kumar A; Beavis RC; Ghiso J Biochem Biophys Res Commun; 1996 Jun; 223(3):592-7. PubMed ID: 8687441 [TBL] [Abstract][Full Text] [Related]
15. Characterization of four lipoprotein classes in human cerebrospinal fluid. Koch S; Donarski N; Goetze K; Kreckel M; Stuerenburg HJ; Buhmann C; Beisiegel U J Lipid Res; 2001 Jul; 42(7):1143-51. PubMed ID: 11441143 [TBL] [Abstract][Full Text] [Related]
16. Remodelling of cerebrospinal fluid lipoproteins after subarachnoid hemorrhage. Kay AD; Day SP; Nicoll JA; Packard CJ; Caslake MJ Atherosclerosis; 2003 Sep; 170(1):141-6. PubMed ID: 12957692 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E in cerebrospinal fluid: relation to phenotype and plasma apolipoprotein E concentrations. Yamauchi K; Tozuka M; Nakabayashi T; Sugano M; Hidaka H; Kondo Y; Katsuyama T Clin Chem; 1999 Apr; 45(4):497-504. PubMed ID: 10102909 [TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of apolipoprotein E in pediatric patients with invasive bacterial infections. Wang C; Wang Y; Wang A; Fu P; Yang Y Clin Biochem; 2012 Feb; 45(3):215-8. PubMed ID: 22178110 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid apolipoprotein E, calcium and cerebral vasospasm after subarachnoid hemorrhage. Alexander SA; Kerr ME; Balzer J; Horowitz M; Kassam A; Kim Y; Hoffman L; Conley YP Biol Res Nurs; 2008 Oct; 10(2):102-12. PubMed ID: 18829593 [TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid apolipoprotein E concentration decreases after seizure. Wang L; Han Y; Chen D; Xiao Z; Xi Z; Xiao F; Wang X Seizure; 2010 Mar; 19(2):79-83. PubMed ID: 20093050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]